RSA Forthcoming Events Calendar

The Pharma Summit 2012
9th February – Hotel Russell, 1-8 Russell Square, Bloomsbury, London, WC1B 5BE

The pharma industry is facing some difficult strategic choices. As the costs of R&D escalate, other more reliable revenue streams look increasingly attractive.

What are the best bets? Will big pharma in its current incarnation even be around in 10 years time? And will it be new business models or technological innovations that fundamentally change the industry?

Every year we identify those trends that have the potential to truly transform the pharmaceutical industry, bringing together leading thinkers and experts who will unlock a fresh perspective.

Chaired by Geoffrey Carr, Science Editor of The Economist, this year's Pharma Summit will focus on emerging healthcare models and discuss what part pharma will play over the next five to 10 years.

For more information please visit http://www.economistconferences.co.uk

If you would like to arrange an informal meeting with one of the RSA team please contact Dani Gransby on +44 1707 282028 or dani.gransby@theRSAgroup.com

BIA BIO Networking Breakfast Meeting
21st February - Fasken Martineau LLP, 17 Hanover Square, London, W1S 1HU

RSA is proudly sponsoring the BIA BIO Networking breakfast meeting.

It’s not just banks and VCs that fund the UK biosciences sector – the biopharmaceutical sector, medical research charities and government health departments play a role as well. The importance of these alternative sources of finance is emphasised by recent data which indicated that more than 10 corporate venture funds had been formed since 2007, as well as the fact that large charities are increasingly open to risk-sharing deals. In this thought-provoking session you will hear from providers of these important sources of capital and a discussion on the options available.

For more information please visit https://www.biaevents.org

If you would like to arrange an informal meeting with one of the RSA team please contact Dani Gransby on +44 1707 282028 or dani.gransby@theRSAgroup.com

Assessing the Safety of Biological Medicines, Biosimilars and Advanced Therapies throughout the Product Lifecycle
23rd February - The Wellcome Collection, 183 Euston Road, London NW1 2BE

This joint BIA/MHRA conference will provide the opportunity for organisations involved in the development of biopharmaceuticals, as well as regulators and service providers, to gain insights on the management of safety issues from industry colleagues and senior experts at UK and European regulatory agencies. The conference will discuss the approach to safety throughout the life cycle and will provide an update on changes to the EU pharmacovigilance system.

The event, co-chaired by Dr Ian Hudson, Director of Licensing Division, MHRA and Member of EMA’s Committee for Medicinal Products for Human Use (CHMP) and Alan Morrison, Chairman of BIA Regulatory Affairs Advisory Committee, Vice President, International Regulatory Affairs and Safety, Amgen, is the ideal place for networking and will bring those involved in regulating and developing these products together to discuss solutions to the challenges in this important area of medicine regulation.

For more information please click here

Nicola Harding and Edith Udemezue will be attending this event. If you would like to meet with either of them please contact Laura Clark on +44 207 299670 or laura.clark@theRSAgroup.com

Biosimilars Congregation 2012
24th February - Hilton London Euston,17-18 Upper Woburn Place, Bloomsbury, London WC1H 0HT

Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars.

For more information please click here

Chantal Williams will be attending this event. If you would like to meet with her please contact Helen Watson on +44 1707 259333 or helen.watson@theRSAgroup.com

BIA Research and Development Conference
28th February - London, England

RSA are proudly sponsoring the BIA Research and Development Conference.

The future is looking good for life sciences R&D in the UK. With recent data from EP Vantage suggesting that R&D productivity might be turning a corner, and with the UK excelling in many of the therapeutic and technical areas expected to generate the most value in the coming years, it’s time to take a fresh look at what’s going on in this exciting environment.

Building on previous R&D conferences, which set the stage for increased collaboration across companies, charities, academia and the public sector, from biotech and pharma, to devices and diagnostics companies, the 2012 conference will focus on how this is being turned into action.

The conference will show you how to make your organisation a force to be reckoned with in this multi-partner world and will be the place to connect and network with the whole of the UK life science sector.

For more information please click here

Darren Spevick, Nicola Harding and Kay Wardle will be attending this event. If you would like to meet with them please contact Sarah Hinchliffe on +44 1707 259333 or sarah.hinchliffe@theRSAgroup.com

PharmaTimes Directors Club - 'Medicines management is the enemy of innovation'
9th March - The King's Fund, 11-13 Cavendish Square, London, W1G 0AN

RSA are proudly sponsoring the BIA Research and Development Conference.

There is real and present industry concern that the medical management community is over-focused on medicine costs rather than health outcomes. The authors of the report 'The Innovation Health and Wealth - Accelerating Adoption and Diffusion in the NHS' recognise this concern and respond to PDC Members and guests.

For more information please click here

Darren Spevick will be attending this event. If you would like to meet with him please contact Miranda Grogan on +44 1707 259333 or miranda.grogan@theRSAgroup.com

Ready to launch? Preparing for International growth
15th March -The King’s Fund, 11–13 Cavendish Square, London W1G 0AN

There is little doubt that when it comes to expanding your recruitment business into new countries, regions and continents, that preparation is key. It is not simply a case of picking a burgeoning hot spot and away you go. The nuances may be subtle in many aspects of overseas recruitment, compared to the UK, but getting them wrong can be very costly.

This day-long summit will give a thorough overview of not only the obvious benefits of global expansion, but also the potential pitfalls. Where should you be looking for your first move and what are the burgeoning regions? Experts who thoroughly analyse data on a daily basis will be on hand to provide answers. Then there is tax, politics and legal issues as well as cultural conundrums to consider. We have compiled leaders in their respective fields to deal with these topics. If you are considering your first or next move overseas then listening to those with practical advice is priceless.

For more infromation please visit www.theglobalrecruiter.com/events

John Callagher will be attending this event. If you would like to meet with him please contact Dani Gransby on +44 1707 282028 or dani.gransby@theRSAgroup.com

BioTrinity 2012
24th to 26th April - Newbury Racecourse, Newbury, Berkshire, England

BioTrinity is the premier European Early Stage Biopartnering and Investment Conference, where great minds and smart money meet under one roof. BioTrinity partners R&D companies and big pharma with more biomedical investors than any other European partnering conference. BioTrinity's early-stage company showcase profiles assets at all stages of development from discovery, pre-clinical, phase I to phase II as well as phase III, rather than marketed products.

Perry Evans, Darren Spevick and Nicola Harding will be representing RSA at this event. If you would like to arrange an informal meeting with them please contact Emma Goodbrand on +44 1707 228606 or emma.goodbrand@theRSAgroup.com